Impact of the type of diagnostic assay on clostridium difficile infection and complication rates in a mandatory reporting program

Clinical Infectious Diseases

Volumn 56, Issue 1, 2013, Pages 67-73

  Longtin, Yves ^a,b   Trottier, Sylvie ^a,b   Brochu, Gilles ^a   Paquet Bolduc, Bianka ^a   Garenc, Christophe ^c   Loungnarath, Vilayvong ^b   Beaulieu, Catherine ^b   Goulet, Danielle ^a   Longtin, Jean ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Clostridium difficile; epidemiology; laboratory diagnosis; nosocomial infections; surveillance

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUTAMATE DEHYDROGENASE;

ALGORITHM; ARTICLE; CELL CULTURE CYTOTOXICITY ASSAY; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COLON RESECTION; CYTOTOXICITY TEST; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MANDATORY REPORTING; MORTALITY; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VALIDATION PROCESS;

ALGORITHMS; BACTERIOLOGICAL TECHNIQUES; CANADA; CHI-SQUARE DISTRIBUTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FECES; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MANDATORY REPORTING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 84871216196     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis840     Document Type: Article

References (40)

1. Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377:63-73.
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9.
3. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41.
4. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12(suppl 6):2-18.
5. Haustein T, Gastmeier P, Holmes A, et al. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis 2011; 11:471-81.
6. Lambert ML, Mertens K, Ramboer I, Delmee M, Suetens C. Nationwide prospective surveillance of Clostridium difficile infections in hospitals in Belgium, July 2007-June 2008. Euro Surveill 2009; 14:2-4.
7. Goldenberg SD, French GL. Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect 2011; 79:4-7.
8. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-5.
9. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
10. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009; 15:1053-66.
11. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, Kuijper EJ. Characteristics and incidence of Clostridium difficile-associated disease in the Netherlands, 2005. Clin Microbiol Infect 2007; 13:1058-64.
12. Viseur N, Lambert M, Delmee M, Van Broeck J, Catry B. Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium: compulsory surveillance data from 2008 to 2010. Euro Surveill 2011; 16:1-5.
13. Gastmeier P, Weitzel-Kage D, Behnke M, Eckmanns T. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents 2009; 33(suppl 1): S19-23.
14. Gravel D, Miller M, Simor A, et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48:568-76.
15. Alcala L, Marin M, Martin A, et al. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey. J Hosp Infect 2011; 79:13-7.
16. American Society for Microbiology. A practical guidance document for the laboratory detection of toxigenic Clostridium difficile, 2010. Available at: http://archive.asm.org/asm/images/pdf/Clinical/clostridi umdifficile9-21.pdf. Accessed 30 August 2012.
17. Wilcox MH, Planche T, Fang FC, Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection? J Clin Microbiol 2010; 48:4347-53.
18. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007; 45:1152-60.
19. Planche T, Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol 2011; 64:1-5.
20. Kufelnicka AM, Kirn TJ. Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis 2011; 52:1451-7.
21. Planche T, Aghaizu A, Holliman R, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008; 8:777-84.
22. Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2011; 53:e81-90.
23. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Infect Control Hosp Epidemiol 2010; 31:939-47.
24. Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007; 44:238-44.
25. Institut National de Santé Publique du Québec. Surveillance des diarrhées associées à Clostridium difficile au Québec. Bilan du 16 août 2009 au 14 août 2010. Available at: http://www.inspq.qc.ca/pdf/publications/1294-SurvCDifficile2009-2010.pdf. Accessed 28 March 2012.
26. Institut National de Santé Publique du Québec. Surveillance des diarrhées associées à Clostridium difficile au Québec: bilan du 15 août 2010 au 4 décembre 2010. Available at: http://www.inspq.qc.ca/pdf/publications/1368-RappSurvCDifficile- AoutDecembre2010.pdf. Accessed 28 March 2012.
27. Institut National de Santé Publique du Québec. Surveillance des diarrhées associées à Clostridium difficile au Québec: bilan du 5 décembre 2010 au 31 mars 2011. Available at: http://www.inspq.qc.ca/pdf/publications/1389-SurvCDifficile- 5dec2010Au31mars2011.pdf. Accessed 28 March 2012.
28. Quebec National Institute of Public Health (INSPQ). Protocol for surveillance of Clostridium difficile associated diarrhea in Quebec acute care hospitals (version 2). 2010. Quebec City, Quebec Health Ministry. Available at: http://www.inspq.qc.ca/aspx/docs/InfectionsNosocomia les/SPIN/GuidemedicalDACD- v1.8.pdf. Accessed 28 April 2012.
29. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35(suppl 2):S65-164.
30. McKibben L, Horan TC, Tokars JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 2005; 26:580-7.
31. Goldenberg SD, Price NM, Tucker D, Wade P, French GL. Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy? J Infect 2011; 62:363-70.
32. Fong KS, Fatica C, Hall G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011; 32:932-3.
33. de Jong E, de Jong AS, Bartels CJ, van der Rijt-van den Biggelaar C, Melchers WJ, Sturm PD. Clinical and laboratory evaluation of a realtime PCR for Clostridium difficile toxin A and B genes. Eur J Clin Microbiol Infect Dis 2012; 31:2219-25.
34. Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M. Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada. Antimicrob Agents Chemother 2012; 56:639-46.
35. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365:1693-703.
36. Guerrero DM, Chou C, Jury LA, Nerandzic MM, Cadnum JC, Donskey CJ. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin Infect Dis 2011; 53:287-90.
37. Stamper PD, Alcabasa R, Aird D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 2009; 47:373-8.
38. Babady NE, Stiles J, Ruggiero P, et al. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 2010; 48:4519-24.
39. Deshpande A, PasupuletiV, Patel P, et al. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol 2011; 9:665-9 e1.
40. Sydnor ER, Lenhart A, Trollinger B, et al. Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies. Infect Control Hosp Epidemiol 2011; 32:1133-6.